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Abstract
Aim Crohn’s disease (CD) requires a multidisciplinary
approach and surgery should be undertaken by dedi-
cated colorectal surgeons with audited outcomes. We
present a national, multicentre study, with the aim to
collect benchmark data on key performance indicators
in CD surgery, to highlight areas where standards of
CD surgery excel and to facilitate targeted quality
improvement where indicated.
Methods All patients undergoing ileocaecal or redo
ileocolic resection in the participating centres for pri-
mary and recurrent CD from June 2018 to May 2019
were included. The main objective was to collect
national data on hospital volume and practice variations.
Postoperative morbidity was the primary outcome.
Laparoscopic surgery and stoma rate were the secondary
outcomes.
Results In all, 715 patients were included: 457 primary
CD and 258 recurrent CD with a postoperative mor-
bidity of 21.6% and 34.7%, respectively. Laparoscopy
was used in 83.8% of primary CD compared to 31% of
recurrent CD. Twenty-five hospitals participated and
the total number of patients per hospital ranged from 2
to 169. Hospitals performing more than 10 primary
CD procedures per year showed a higher adoption of
laparoscopy and bowel sparing surgery.
Conclusions There is significant heterogeneity in the
number of CD surgeries performed per year nationally in
Italy. Our data suggest that high-volume hospitals per-
form more complex procedures, with a higher adoption
of bowel sparing surgery. The rate of laparoscopy in
high-volume hospitals is higher for primary CD but not
for recurrent CD compared with low-volume hospitals.
Keywords Crohn’s disease, inflammatory bowel dis-
ease, ileocaecal resection, colorectal surgery, national
audit
What does this paper add to the literature?
Twenty-five hospitals participated in this national multi-
centre study including 715 patients who underwent
ileocaecal or redo ileocolic resection for Crohn’s disease
during a 12-month study period. High-volume hospi-
tals perform more complex procedures, with a higher
adoption of bowel sparing surgery.
Introduction
Patients with Crohn’s disease (CD) affecting the termi-
nal ileum have a high risk of requiring surgery at least
once during their lifetime, with common indications for
surgery including abscesses, complex internal fistulas
and fibrostenotic strictures [1]. Surgery for CD carries a
high risk of complications including wound infections,
anastomotic leak and intra-abdominal sepsis, which are
made more likely by immune suppression, malnutrition
and penetrating or recurrent disease. Despite surgery
many patients can develop recurrence and require long-
term medical treatment and eventually further surgery
[2]. For these reasons, patients with CD require a mul-
tidisciplinary approach and when surgery is undertaken
it should be carried out by colorectal surgeons who are
core members of the inflammatory bowel disease (IBD)
multidisciplinary team [3] with audited outcomes [4].
Unfortunately many key performance indicators of CD
surgery such as postoperative morbidity, rate of ileost-
omy formation, reoperations and readmissions are not
routinely recorded, with paucity of audits on Patient
Reported Outcome Measures (PROMs) [5]. We present
a national multicentre study promoted by the Italian
Society of Colorectal Surgery (SICCR) with the aim of
collecting benchmark data to highlight areas where
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standards of CD surgery excel or are substandard and




The SICCR promoted the snapshot study ‘Current Sta-
tus of Crohn’s Disease Surgery’, which is a retrospec-
tive, multicentre, observational study developed
according to the STROBE checklist [6].
The study protocol was developed by the steering
committee and independently reviewed and approved by
the SICCR research board. Ethical approval was obtained
from the promoting centres and every participating cen-
tre had a named principal investigator, liaising with the
local ethics committee. Obtaining informed consent from
the patients was deemed not necessary by the ethics com-
mittees in view of the retrospective nature of the study.
Participating centres were invited directly and by an
open call published on the SICCR website and also dis-
seminated during a 2-month period via the society
newsletter, with reminders sent every 2 weeks.
Eligibility criteria
All consecutive patients (aged 16 or older) undergoing
elective or urgent or emergency ileocaecal or redo ileo-
colic resection for primary and recurrent CD from 1 June
2018 to 31 May 2019 were included. Patients undergo-
ing proctocolectomy, proctectomy or segmental colec-
tomy were excluded from this study. Urgent surgery was
defined as any operation occurring within the same
unplanned hospital admission for a CD flare-up or new
presentation. Emergency surgery was defined as any oper-
ation occurring within 48 hours of an acute CD presen-
tation with obstruction, bleeding or perforation.
Study objectives
The main objective of the study was to collect national
benchmark data to identify good standards of care and
variations. Postoperative morbidity within 30 days of sur-
gery was the primary end-point. Laparoscopic surgery
and stoma rate were the secondary outcome measures.
Data collection
Collected data included patients’ demographics, Montreal
classification, preoperative imaging and medical treatment,
indication for surgery, American Society of Anesthesiolo-
gists (ASA) grade, operative details such as main procedure
performed and use of strictureplasties, and key perfor-
mance indicators in CD surgery (ileostomy rate, surgical
access and conversion rate, length of hospital stay, 30-day
postoperative morbidity, readmissions and reoperations).
The presence of a multidisciplinary team, with regular
input from gastroenterologists, dietitians and stoma care
team, was also documented. Data on the use of PROMs
were also collected. Postoperative morbidity was defined
as any complication occurring during the hospital stay or
within 30 days after surgery, whilst all readmissions were
recorded up to 30 days after discharge.
Definition of low-, mid- and high-volume hospitals
There is no standard definition for high-volume IBD sur-
gery hospitals. A UK consensus panel recognized that an
IBD unit should be carrying out more than 20 major
intra-abdominal IBD operations each year [5]. However,
this definition included all IBD related procedures, whilst
the focus of our study was CD, with particular reference to
primary and recurrent disease. Acknowledging the lack of
a widely accepted denotation for a high-volume CD hospi-
tal, the steering committee of our study adopted the fol-
lowing definitions: low-volume, 10 or fewer procedures
per year; mid-volume, between 11 and 20 procedures per
year; high-volume, more than 20 procedures per year.
Statistical analysis
Categorical variables are presented as frequency and per-
centages, and were compared using the chi-squared test
or Fisher’s exact test, as appropriate. Continuous vari-
ables are presented as mean (standard deviation) or
median (range) according to their distribution, and
were compared with the use of Student’s t test or the
Mann–Whitney U test in the case of normal or skewed
distribution, respectively. To identify variables associated
with binary outcomes, univariate and multivariate logis-
tic regression analyses were performed. Variables having
a P value equal to 0.10 or less in the univariate analysis
were included in the multiple regression model. The
odds ratio with a 95% confidence interval was estimated
as a measure of association.
All reported P values were two-tailed, and P values
< 0.05 were considered to be statistically significant.
Statistical analysis was performed by using IBM SPSS
Statistics for Windows, version 25.0 (IBM Corp.,
Armonk, New York, USA).
Results
Twenty-five hospitals participated and 715 patients were
included; 457 patients had surgery for primary CD,
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whilst 258 patients had surgery for recurrent CD
(Table 1). Every hospital was allocated a unique identi-
fier number (ID).
The total number of patients per hospital ranged
from 2 to 169, whilst the number of primary CD and
recurrent CD procedures ranged from 1 to 99 and from
1 to 70, respectively, as demonstrated in Fig. 1.
Preoperative imaging and medical treatment
In patients undergoing primary CD surgery, MRI was
the most commonly applied imaging technique
(70.7%). Ultrasound scan (USS) and CT were used in
53.4% and 53.1% of the patients, respectively. Capsule
endoscopy was rarely used (1.7%). Data on preoperative
medical treatment in the primary surgery group are
summarized in Appendix S3.
Similarly, MRI (65.3%) and USS (59.7%) were the
most commonly used imaging modalities in patients
with recurrent CD, whilst CT and capsule endoscopy
were only used in 39.1% and 2.4% of the patients
respectively. Data on preoperative medical treatment in
the recurrent surgery group are shown in Appendix S4.
Laparoscopic surgery and stoma rate
The use of laparoscopic surgery differed significantly
between primary (83.8%) and recurrent (31%) CD sur-
gery (P < 0.0001). The conversion rate was 8.9% and
13% for primary and recurrent CD surgery, respectively
(P = 0.3).
In the group of patients undergoing surgery for pri-
mary CD the ileostomy rate was 11.6%, compared to
19.7% in the recurrent CD group (P = 0.0018).
Postoperative morbidity and anastomotic leak rate
Postoperative complications were observed in 99
(21.6%) patients in the primary CD surgery group com-
pared to 86 (34.7%) in the recurrent CD group
(P < 0.0001). Clavien–Dindo Grade 3 or higher com-
plications occurred in 37 (8.1%) and 30 (11.6%)
Table 1 Seven hundred and fifteen included patients.
Primary N % Recurrent N % P value
Total number 457 258 < 0.0001
M:F ratio 274:183 131:127 0.02
Age 41 (16–85) 49 (17–80) < 0.0001
BMI 22 (13.5–42) 21.7 (15–40.4) 0.18
ASA score ≥ 3 57 12.5 45 17.4 0.06
Urgency of surgery
Elective 387 84.7 219 84.9 0.86
Urgent 61 13.3 35 13.5 0.19
Emergency 7 1.5 4 1.5 0.91
Preoperative management
MDT discussion 306 66.9 170 65.9 0.7
Stoma nurse review 127 27.8 73 28.3 0.75
Dietitian review 128 28 79 30.6 0.54
TPN 46 10 54 20.9 0.0001
Preoperative medical treatment
Steroids 148 32.4 82 33 0.86
Immunosuppressors 51 11.1 33 13.3 0.38
Anti-TNF 69 15.1 38 15.3 0.94
Ileostomy 53 11.6 49 19.7 0.003
Laparoscopy 383 83.8 77 31 <0.0001
Conversion to open 34 8.9 10 13 0.38
LOS 7 (3–95) 8 (3–230)
Complications 99 21.6 86 34.7 0.0001
Clavien–Dindo ≥ 3 37 8.1 30 11.6 0.11
Reoperations 19 4.1 18 7.2 0.04
Readmissions 25 5.5 17 6.8 0.29
Anti-TNF, anti-tumour necrosis factor; ASA, American Society of Anesthesiologists; BMI, body mass index; F, female; LOS, length
of hospital stay; M, male; MDT, multidisciplinary team; N, number; TPN, total parenteral nutrition.
Data are expressed as number (%) or median (range).
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patients in the primary CD and recurrent CD group
respectively (P = 0.11). The anastomotic leak rate was
3.7% in the primary compared to 7.1% in the recurrent
CD group (P = 0.05). There were 19 reoperations
(4.1%) and 25 readmissions (5.5%) in the primary CD
surgery group, compared to 18 (7.2%) and 17 (6.8%) in
the recurrent CD group (P = 0.03 and P = 0.42).
There was one death (0.2%) in the primary group com-
pared to none in the recurrent.
The hospitals in the upper quartile for number of
procedures performed (19.5 procedures for primary CD
and 13.5 for recurrent CD, respectively) reported a
mean postoperative morbidity of 23.3% ranging from
15.8% to 45% for primary CD and of 37.5% ranging
from 17.6% to 53.3% for recurrent CD.
Surgical outcomes according to number of primary
CD surgeries performed in each hospital
Ten hospitals (40%) performed 10 or fewer (low vol-
ume) primary CD surgeries per year, whilst 11 (44%)
performed between 11 and 20 cases per year (mid-vol-
ume) and only four (16%) performed more than 20
resections (high volume). Table 2 demonstrates that
there was significant heterogeneity in the postoperative
morbidity and stoma rate across the 25 participating
centres, as shown in Figs 2 and 3.
Laparoscopic surgery (Fig. 4) was used in 64% of the
patients in low-volume hospitals, compared to 79.4%
and 91.4% in the mid- and high-volume hospitals,
respectively (P < 0.0001).
Forty-five patients (9.8%) had one or more stricture-
plasties at the same time as the ileocaecal resection.
Interestingly, strictureplasties were never used in the
patients who had surgery for primary CD in hospitals
performing 10 or fewer procedures per year, compared
to 13.1% of the patients operated in mid-volume hospi-
tals and 9.5% in high-volume hospitals (P < 0.0001).
At least one additional procedure (strictureplasty,
small bowel resection or segmental colectomy) was
required at the same time as the ileocaecal resection in
114 patients (24.9%). The rate of required additional
procedures according to hospital volume was 8% (low-
volume hospitals), 27.4% (mid-volume hospitals) and
26.7% (high-volume hospitals) (P < 0.0001).
Univariate and multivariate analysis for postoperative
morbidity and ileostomy formation in primary CD
surgery
ASA grade ≥ 3 (OR 3.21, 95% CI 1.61–6.39,
P = 0.001) and the performance of associated surgical
procedures (OR 2, 95% CI 1.14–3.52, P = 0.015) at
the same time as the ileocaecal resection were associated
with postoperative complications, as shown in Table 3,
whilst a penetrating phenotype of disease (OR 3.32,
95% CI 1.49–7.38, P = 0.003) and conversion to open
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Figure 1 Number of procedures performed in each participating hospital for primary and recurrent Crohn’ disease (CD).
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associated with ileostomy formation (Table 3). The use
of minimally invasive surgery correlated with reduced
postoperative morbidity (OR 0.45, 95% CI 0.22–0.92,
P = 0.03) and stoma rate (OR 0.17, 95% CI 0.07–
0.41, P < 0.001). There was no correlation with preop-
erative medical treatments for both outcomes.
Surgical outcomes according to number of recurrent
CD surgeries performed in each hospital
Only 24 hospitals performed recurrent CD surgery. Six-
teen hospitals (66.6%) performed 10 or fewer (low vol-
ume) recurrent CD surgeries per year, whilst six (25%)
performed between 11 and 20 cases per year (mid-vol-
ume) and only two (8.3%) performed more than 20
resections (high volume).
Table 4 demonstrates the significant heterogeneity in
the postoperative morbidity (Fig. 5), use of laparoscopy
and stoma rate (Fig. 6) amongst the 24 participating
centres.
Differently from primary CD surgery, laparoscopic
surgery (Fig. 7) was used in 46.1% of the patients in
low-volume hospitals, compared to 28.4% and 17.4% in
the mid- and high-volume hospitals, respectively.
Twenty-nine patients (12.1%) had one or more stricture-
plasties at the same time as the redo ileocolic resection. Simi-
lar to the results of primary CD surgery, strictureplasties
were never used at the same time as the redo ileocolic resec-
tions in patients undergoing surgery in low-volume hospi-
tals, compared to 6.8% and 20.6% in mid- and high-volume
hospitals, respectively (P < 0.0001).
At least one additional procedure (strictureplasty, small
bowel resection or segmental colectomy) was required at
the same time as the redo ileocolic resection in 60 patients
(23.2%). The rate of required additional procedures was
2.5% in low-volume hospitals, 18.2% in mid-volume hospi-
tals and 34.7% in high-volume hospitals (P < 0.0001).
Univariate and multivariate analysis for postoperative
morbidity and ileostomy formation in recurrent CD
surgery
Similar to primary CD, the performance of associated
surgical procedures (OR 2.82, 95% CI 1.24–4.17,










N (%) AL LOS Reop Read
7 1 0 0 1 (100%) 0 0 0 1 (100%) 0 6 0 0
8 2 0 0 0 0 0 0 0 0 9 0 0
14 2 0 0 2 (100%) 0 0 0 1 (50%) 0 6.5 0 0
12 3 2 (66.6%) 1 (33.3%) 2 (66.6%) 0 0 0 0 0 7 0 0
24 4 1 (25%) 0 4 (100%) 0 0 0 1 (25%) 1 11.5 1 0
20 5 1 (20%) 1 (20%) 2 (40%) 0 0 0 1 (20%) 0 6 0 0
2 7 1 14.3%) 0 7 (100%) 0 0 0 1 (14.3%) 1 7 1 0
10 7 3 (42.8%) 0 5 (71.4%) 0 0 0 2 (28.6%) 0 6 0 0
13 9 1 (11.1%) 0 8 (88.8%) 0 0 2 (22.2%) 0 0 5 0 0
11 10 3 (30%) 2 (20%) 1 (10%) 0 0 2 (10%) 4 (40%) 2 8.5 2 0
22 12 5 (41.7%) 3 (25%) 11 (91.7%) 0 1 (8.3%) 2 (16.7%) 3 (25%) 0 6 1 0
16 13 5 (38.5%) 4 (30.8%) 13 (100%) 1 (7.7%) 0 0 2 (15.4%) 0 6 0 0
19 13 3 (23.1%) 3 (23.1%) 9 (69.2%) 2 (22.2%) 0 0 3 (23.1%) 0 7 0 0
4 14 3 (21.4%) 1 (7.1%) 13 (92.8%) 3 (23%) 2 (14.3%) 4 (28.7%) 1 (7.1%) 1 7.5 1 2
21 15 3 (20%) 0 9 (60%) 2 (22.2%) 2 (13.3%) 2 (13.3%) 1 (6.7%) 0 9 0 0
9 16 7 (43.7%) 2 (12.5%) 1 (6.2%) 0 1 (6.2%) 9 (56.2%) 2 (12.5%) 0 7.5 0 0
18 16 4 (25%) 1 (6.2%) 12 (75%) 0 5 (27.8%) 8 (50%) 4 (25%) 0 7 0 0
25 17 9 (52.9%) 0 16 (94.1%) 3 (18.7%) 4 (23.5%) 5 (29.4%) 4 (23.5%) 0 5 2 2
6 19 3 (15.8%) 0 19 (100%) 1 (5.3%) 1 (5.3%) 2 (10.5%) 4 (21%) 2 5 0 1
1 20 9 (45%) 3 (15%) 19 (95%) 0 4 (20%) 10 (50%) 4 (20%) 1 6 1 4
23 20 5 (25%) 2 (10%) 17 (85%) 3 (17.7%) 3 (15%) 6 (30%) 9 (45%) 3 6 3 2
5 29 5 (17.2%) 0 27 (93.1%) 1 (3.7%) 2 (6.9%) 6 (20.7%) 5 (17.2%) 0 7 1 3
3 41 20 (48.8%) 4 (9.7%) 37 (90.2%) 0 10 (24.4%) 10 (24.4%) 7 (17%) 2 10 1 0
15 63 2 (3.2%) 10 (15.9%) 59 (93.6%) 4 (6.8%) 4 (6.3%) 10 (15.9%) 10 (15.8%) 1 5 1 1
17 99 38 (38.4%) 16 (16.1%) 89 (89.9%) 14 (15.7%) 6 (6%) 36 (36.4%) 29 (29.3%) 3 8 4 10
All 457 133 (29.1%) 53 (11.6%) 383(83.8%) 34 (8.9%) 45 (9.8%) 114 (24.9%) 99 (21.6%) 17 (3.7%) 7 19 (4.1%) 25 (5.5%)
AL, anastomotic leak; ASS PROC, associated procedures at the same time as the ileocaecal resection; CONV, conversion to open;
LAP, laparoscopy; LOS, length of hospital stay; MORB, morbidity; N, number of patients; PEN, penetrating phenotype of disease;
Read, readmissions; Reop, reoperations; SXPL, strictureplasties.
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Figure 2 Postoperative morbidity following primary Crohn’s disease (CD) surgery in 25 participating Italian hospitals.
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Figure 3 Stoma rate following primary Crohn’s disease (CD) surgery in 25 participating Italian hospitals.
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Figure 4 Use of laparoscopy at primary Crohn’s disease (CD) surgery in 25 participating Italian hospitals.
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P = 0.007) was associated with postoperative morbidity
(Table 5), while a penetrating phenotype of disease
(OR 2.67, 95% CI 1.27–5.58, P = 0.09) was associated
with ileostomy formation (Table 5). There was no cor-
relation with preoperative medical treatments for both
outcomes.
Discussion
Our study demonstrated significant heterogeneity across
the 25 participating Italian hospitals in the volume of
CD surgery cases performed per year, the short-term
surgical outcomes and the adoption of minimally inva-
sive surgery and bowel sparing techniques. It is not sur-
prising to highlight variations in IBD surgical practice
as, similarly, the wide range of available treatments for
IBD has been shown to result in significant heterogene-
ity amongst physicians in the use of biologics and com-
bination therapy, confirming the need for standardized
pathways for the care of IBD patients [7].
To reduce this variability the SICCR has recently
published a national position statement with the aim of
standardizing multidisciplinary management and surgi-
cal treatment of CD nationally [8], and guidelines of
several international societies have been released to opti-
mize CD outcomes (e.g. European Crohn’s Colitis
Organization [1], the American Society of Colorectal
Surgery) [9]. A general aim of guidelines is to reduce
variations in practice, by providing evidence-based guid-
ance on the best treatment options with the aim to
enhance patients’ outcomes. It has been previously
reported that hospitals with a high annual IBD volume
have lower in-hospital mortality among surgical IBD
patients. This difference seems to be more significant
for CD rather than ulcerative colitis [10]. In our study,
there was only one death out of the 715 patients under-
going CD surgery (0.14%), highlighting that mortality
is not an appropriate benchmark outcome to compare
performance across different IBD centres. The large
number of patients recruited and the multicentre design
are the main strengths of our study, together with the
focus on key performance indicators of CD surgery,
outcomes which are often not so thoroughly audited as
in cancer surgery [11]. Despite the absence of a central-
ized referral pathway to tertiary IBD units in Italy, our
results suggest that high-volume centres are more likely
to perform the most complex cases. In fact, we found a
3- to 4-fold increase in high-volume centres compared
to low-volume hospitals in the number of patients
undergoing associated surgical procedures such as seg-
mental colonic resections and strictureplasties at the
time of the ileocaecal or redo ileocolic resection. The
assumption of an increased number of more complex
procedures performed in high-volume hospitals may
also explain the lack of increased use of laparoscopic
surgery in recurrent CD, whilst in primary CD surgery
it was preferred to open surgery much more commonly
in high-volume hospitals, with a 1.5-fold increase com-
pared to hospitals performing fewer than 10 procedures
per year. We found a higher risk of postoperative com-
plications following ileocolic resection for recurrent
CD, which confirms previously published data suggest-
ing up to a 3-fold increase in the anastomotic leak rate
compared to primary CD surgery [12], highlighting the
Table 3 Univariate and multivariate analysis for postoperative morbidity and ileostomy formation following primary CD.
Variable
Primary CD – postoperative morbidity Primary CD – stoma formation
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
OR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P
Age 1.02 1.00–1.03 0.035 1.00 0.98–1.02 0.614 1.00 0.98–1.02 0.833
Sex (female) 0.80 0.49–1.28 0.358 0.87 0.47–1.57 0.646
BMI 0.97 0.91–1.03 0.310 0.93 0.85–1.01 0.100 0.89 0.80–0.98 0.023
ASA grade ≥ 3 2.69 1.49–4.84 0.001 3.21 1.61–6.39 0.001 1.87 0.90–3.89 0.091 1.51 0.43–5.26 0.520
Associated procedures (yes) 1.95 1.19–3.19 0.008 2.00 1.14–3.52 0.015 1.99 1.07–3.60 0.025 1.57 0.70–3.52 0.271
Montreal B = 3 1.50 0.92–2.43 0.100 1.32 0.75–2.31 0.332 3.02 1.68–5.45 <0.001 3.32 1.49–7.38 0.003
Montreal L = 3 1.33 0.84–2.13 0.230 1.04 0.58–1.85 0.899
Perianal disease (yes) 0.55 0.23–1.14 0.132 0.96 0.38–2.12 0.930
Preoperative steroids (yes) 1.06 0.65–1.71 0.815 1.30 0.71–2.33 0.390
Preoperative
immunosoppression (yes)
0.98 0.47–2.05 0.974 0.453 0.14–1.51 0.198
Preoperative biologics (yes) 0.60 0.28–1.18 0.165 0.68 0.25–1.54 0.393
Access (laparoscopic surgery) 0.53 0.30–0.94 0.026 0.45 0.22–0.92 0.030 0.23 0.12–0.43 <0.001 0.17 0.07–0.41 <0.001
Conversion (yes) 2.16 1.00–4.45 0.040 1.85 0.83–4.11 0.130 2.71 1.09–6.15 0.022 3.03 1.14–8.05 0.026
ASA, American Society of Anesthesiologists; BMI, body mass index; CD, Crohn’s disease.
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need for judicious use of diverting stomas in this group
of patients, as indicated by our results demonstrating an
ileostomy rate of 19.7% in recurrent CD compared to
11.6% in primary CD.
Certainly, more complex IBD patients are at a higher
risk of postoperative complications, obscuring the rela-
tionship between procedural volume and postoperative
morbidity, as sicker patients may have been referred to
surgeons with greatest experience. However, the rela-
tionship between surgical volume and postoperative
outcomes is probably multifactorial and more complex
than simply surgeon experience, as for example high-
volume hospitals may have more institution-level-related
resources [13]; conversely low-volume hospitals may
have less support available from the multidisciplinary
team, such as gastroenterologists or dietitians.
The European Society of Coloproctology previously
reported the results of a snapshot study including 375
CD patients who underwent surgery in 151 centres
over a 2-month period in 37 different countries [14].
The audit excluded patients who underwent additional
procedures such as strictureplasties at the time of the
surgery. The complication rate was 33.6% and the
stoma rate was 12.3%. The authors reported as key find-
ings of the study that parenteral nutrition, urgent oper-
ations and intra-operative complications were associated
with a higher risk of postoperative complications.
Our study collected self-reported data from 25 dif-
ferent hospitals to describe the current status of CD
surgery in Italy. These hospitals were invited by an open
call and newsletter promoted by the SICCR, which we
believe somehow selected for participation the hospitals
where a dedicated colorectal/IBD team was established,
which not necessarily reflects the practice taking place
all over Italy and might have left uninvolved other small
hospitals not participating in the activities of the
national colorectal surgery society. The self-reporting
nature of the data may also account for the significant
heterogeneity of our results in relation to postoperative
morbidity, ranging from 0% to 100%. The risk of infor-
mation and recall bias is intrinsic to the design of retro-
spective studies and might have affected those centres
needing to manually retrieve data for up to 12 months.
Conversely, a more cohesive incidence of postoperative
morbidity might have been demonstrated by the hospi-
tals already maintaining a prospective database, in
Table 4 Laparoscopy, stoma rate, associated resections and morbidity for recurrent Crohn’s disease surgery in the 24 participating
hospitals.
ID N PEN Stoma N (%) LAP CONV SXPL ASS PROC MORB N (%) AL LOS Reop
16 1 1 (100%) 1 (100%) 0 (0%) NA 0 0 1 (100%) 0 26 0
7 1 1 (100%) 0 (0%) 0 (0%) NA 0 0 0 (0%) 0 9 0
8 2 0 0 (0%) 0 NA 0 0 0 (0%) 0 11.5 0
11 3 2 (66.6%) 1 (33.3%) 0 (0%) NA 0 1 (33.3%) 0 (0%) 0 8 0
12 3 0 0 (0) 2 (66.6%) 0 (0%) 0 0 1 (33.3%) 1 (33.3%) 8 1 (33.3%)
13 3 1 (33.3%) 1 (33.3%) 1 (33.3%) 0 (0%) 0 1 (33.3%) 1 (33.3%) 0 11 0
14 4 0 0 (0%) 4 (100%) 0 (0%) 0 0 0 (0%) 0 7 0
2 4 0 1 (25%) 1 (25%) 0 (0%) 0 0 0 (0%) 0 8.5 0
21 4 1 (25%) 2 (50%) 0 NA 0 0 2 (50%) 0 15.5 0
10 6 5 (83.3%) 1 (16.7%) 2 (33.3%) 0 0 0 1 (16.7%) 0 6 0
22 6 0 0 (0%) 4 (66.7%) 1 (25%) 2 (33.3%) 2 (33.3%) 2 (33.3%) 1 (16.7%) 6.5 1 (16.7%)
6 7 2 (28.6%) 1 (14.3%) 6 (85.7%) 0 (0%) 2 (28.6%) 3 (42.8%) 2 (28.6%) 2 (28.6%) 4 2 (28.6%)
20 7 3 (42.8%) 1 (14.3%) 1 (14.3%) 0 (0%) 0 3 (42.8%) 2 (28.6%) 0 6 1 (14.3%)
19 8 1 (12.5%) 1 (12.5%) 6 (75%) 1 (16.6%) 0 0 0 0 6.5 0
1 9 5 (55.5%) 1 (11.1%) 8 (88.9%) 0 (0%) 0 1 (11.1%) 5 (55.5%) 1 (11.1%) 6 1 (11.1%)
4 10 5 (50%) 2 (20%) 1 (10%) 0 (0%) 0 2 (20%) 3 (30%) 1 (10%) 8 1 (10%)
25 11 5 (45.4%) 0 (0%) 7 (63.3%) 1 (14.3%) 0 1 (9.1%) 4 (36.4%) 1 (9.1%) 5 0
9 12 2 (16.7%) 3 (25%) 0 (0%) NA 0 2 (16.7%) 3 (25%) 1 (8.3%) 8 1 (8.3%)
18 15 4 (26.7%) 3 (20%) 1 (6.7%) 0 (0%) 0 2 (13.3%) 5 (33.3%) 0 8 0
23 15 5 (33.3%) 7 (46.7%) 3 (20%) 2 (66.7%) 1 (6.7%) 3 (33.3%) 8 (53.3%) 0 8 0
5 17 2 (11.8%) 2 (11.7%) 4 (23.5%) 0 (0%) 4 (23.5%) 5 (29.4%) 3 (17.6%) 1 (5.9%) 7 1 (5.9%)
15 18 3 (16.7%) 6 (33.3%) 10 (55.5%) 4 (40%) 1 (5.5%) 3 (16.7%) 5 (27.8%) 1 (5.5%) 6 0
3 22 14 (63.6%) 0 (0%) 7 (31.8%) 0 (0%) 9 (40.9%) 11 (50%) 7 (31.8%) 1 (4.5%) 15.5 1 (4.5%)
17 70 23 (32.8%) 15 (21.4%) 9 (12.8%) 1 (11.1%) 10 (4.3%) 21 (30%) 31 (44.3%) 6 (8.6%) 8 8 (11.4%)
All 248 85 (34.3%) 49(19.7%) 77 (31%) 10 (13%) 29 (11.7%) 61 (24.6%) 86 (34.7%) 17 (7.1%) 8 18 (7.2%)
AL, anastomotic leak; N, number of patients; PEN, penetrating phenotype of disease; LAP, laparoscopy; CONV, conversion to
open; ASS PROC, associated procedures at the same time as the redo ileocolic resection; MORB, morbidity; AL, anastomotic leak;
LOS, length of hospital stay; Reop, Reoperations; SXPL, strictureplasties.
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Figure 5 Postoperative morbidity following recurrent Crohn’s disease (CD) surgery in 24 participating Italian hospitals.
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Figure 6 Stoma rate following recurrent Crohn’s disease (CD) surgery in 24 participating Italian hospitals.
1.000











0 20 40 60
Number of cases by center
Figure 7 Use of laparoscopy at recurrent Crohn’s disease (CD) surgery in 24 participating Italian hospitals.
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keeping with recent literature reporting a postoperative
morbidity of 24% following ileocolic CD surgery [15].
The subgroup analysis of the postoperative morbidity
we performed for the hospitals in the upper quartile
according to number of procedures performed found
similar results, reporting an overall morbidity of 23.3%
for primary CD and 37.5% for recurrent CD. Neverthe-
less, this subgroup analysis was outside the objectives
and scope of this study, but confirms the need for high
quality prospective data. Participation in national and
international prospective IBD databases should be
implemented into clinical practice as part of a quality
improvement programme guided by surgical societies,
in order to maintain high standards of practice and to
allow local auditing and action when the reported out-
comes fall well below these standards.
Urgent action must also be taken to address the lack
of standardized PROMs assessment, with approximately
1% of the patients currently being formally evaluated for
functional outcomes following CD surgery, as found in
our study.
The retrospective nature of the study and the limited
number of procedures performed in some hospitals limit
our results. These may also explain the relatively low
rate of readmission (6%) found in our study compared
to 8% in a previously published large case series [16].
Moreover some of the participating centres performed a
significant proportion of the 715 included procedures,
with one centre for example performing 99 resections
for primary CD and 70 for recurrent CD. Nevertheless,
the subgroup analysis we performed according to hospi-
tal volume was an attempt to evaluate the influence of
single centres on the overall results. There is no agree-
ment on the required number of surgical procedures
per year for the definition of a high-volume CD surgery
hospital. The minimum number of 20 IBD surgeries
per year, suggested by a European consensus group [5],
does not take into consideration the multitude of pro-
cedures performed in patients with IBD, with the possi-
ble implication that units performing many colectomies
and ileoanal pouches for ulcerative colitis and only a
limited number of CD surgeries might be identified as
‘high volume’ [17]. The approach adopted in our
study, which stratifies hospitals according to the number
of procedures performed for the specific operation of
ileocolic resection in the setting of primary or recurrent
CD, is much more likely to generate meaningful data.
The decision on the minimum number of procedures to
be performed to achieve acceptable standards in CD
surgery should not be based on retrospectively collected
data; however, our study supports the hypothesis that
the most complex patients may benefit from being cared
for in high-volume centres, with the need for confirma-
tion in a mandatory prospective registry.
Conclusions
There is significant heterogeneity in the number of CD
surgeries performed per year in each hospital in Italy.
Our data suggest that high-volume hospitals perform
more complex procedures, with a higher adoption of
bowel sparing surgery. The rate of laparoscopy in high-
volume hospitals is higher for primary CD but not for
recurrent CD compared to low-volume hospitals. A
Table 5 Univariate and multivariate analysis for postoperative morbidity and stoma formation following recurrent CD surgery.
Variable
Recurrent CD – postoperative morbidity Recurrent CD – stoma formation
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
OR 95% CI P OR 95% CI P OR 95% CI OR 95% CI OR 95% CI
Age 0.99 0.98–1.01 0.562 0.96 0.48–1.85 0.896
Sex (female) 0.84 0.49–1.43 0.525 0.96 0.48–1.85 0.896
BMI 1.00 0.93–1.07 0.949 0.90 0.81–0.98 0.022 0.92 0.84–1.02 0.106
ASA grade ≥ 3 1.66 0.85–3.22 0.135 1.53 0.71–3.31 0.273
Associated procedures (yes) 2.46 1.37–4.40 0.002 2.82 1.24–4.17 0.007 1.07 0.52–2.18 0.849
Montreal B = 3 1.77 1.02–3.08 0.040 1.57 0.88–2.78 0.124 2.95 1.56–5.60 0.001 2.67 1.27–5.58 0.009
Montreal L = 3 0.97 0.55–1.70 0.922 1.67 0.82–3.22 0.164
Perianal disease (yes) 1.26 0.68–2.30 0.453 2.05 1.03–4.01 0.038 0.36 0.12–0.99 0.278
Preoperative steroids (yes) 1.22 0.70–2.13 0.470 1.34 0.56–2.95 0.481
Preoperative
immunosoppression (yes)
1.32 0.63–2.80 0.460 0.23 0.05–1.01 0.053 0.28 0.06–1.30 0.106
Preoperative biologics (yes) 1.03 0.50–2.13 0.925 1.34 0.56–2.95 0.481
Access (minimally invasive) 0.380 0.20–0.72 0.003 0.51 0.26–0.99 0.050 0.21 0.08–0.55 0.002 0.35 0.13–0.99 0.048
Conversion (yes) 0.44 0.09–2.12 0.309 1.13 0.23–5.52 0.876
CD, Crohn’s disease; BMI, body mass index; ASA, American Society of Anesthesiologists.
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prospective national CD surgery registry also incorpo-
rating PROMs evaluation must be established.
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